| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.22B | 41.98B | 41.36B | 38.63B | 37.24B | 32.54B |
| Gross Profit | 12.34B | 12.65B | 13.16B | 12.24B | 11.22B | 9.95B |
| EBITDA | 3.15B | 3.41B | 3.99B | 3.75B | 3.88B | 3.20B |
| Net Income | 951.52M | 1.20B | 1.48B | 1.67B | 2.19B | 1.53B |
Balance Sheet | ||||||
| Total Assets | 46.71B | 47.01B | 47.83B | 43.63B | 40.54B | 37.68B |
| Cash, Cash Equivalents and Short-Term Investments | 6.91B | 6.53B | 8.88B | 6.60B | 6.66B | 5.63B |
| Total Debt | 10.06B | 9.64B | 11.45B | 9.18B | 8.61B | 8.56B |
| Total Liabilities | 21.58B | 20.88B | 22.51B | 19.04B | 17.38B | 16.55B |
| Stockholders Equity | 24.50B | 25.44B | 24.73B | 23.73B | 22.34B | 20.37B |
Cash Flow | ||||||
| Free Cash Flow | -45.76M | 1.12B | 1.92B | 784.70M | 2.50B | 214.86M |
| Operating Cash Flow | 85.64M | 1.71B | 2.63B | 1.86B | 3.14B | 876.88M |
| Investing Cash Flow | -1.01B | -410.03M | -1.77B | -1.87B | -1.55B | -2.22B |
| Financing Cash Flow | -1.06B | -3.38B | 1.12B | -517.24M | -900.07M | 661.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥193.60B | 4.98 | 17.09% | 2.94% | 9.67% | 45.58% | |
76 Outperform | ¥22.89B | 10.49 | ― | 3.83% | 41.87% | 167.99% | |
74 Outperform | ¥51.29B | 13.51 | ― | 4.12% | -4.88% | -26.05% | |
68 Neutral | ¥33.54B | 7.89 | ― | 3.25% | 0.17% | 21.01% | |
65 Neutral | ¥30.39B | -17.27 | ― | 5.16% | 1.71% | -29.37% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ¥36.36B | 40.99 | 1.55% | 1.34% | -34.13% | -31.24% |